Strategies for Working Effectively With Interpreters (30 min.)
This course reviews indications for interpreter use with patients, scope of practice for Approved Bilingual Providers, limitations and harms of ad-hoc interpretation, and best practices in communication when working with an interpreter. The course is intended for physicians, nurses, pharmacists, physician assistants and social workers who provide care for infants and children who may require interpreter services.
This content was created by OPENPediatrics, a peer-reviewed medical education platform for healthcare professionals. Please see www.openpediatrics.org for more information.
$15.00
Description
This content was created by OPENPediatrics, a peer-reviewed medical education platform for healthcare professionals. Please seewww.openpediatrics.orgfor more information.
Learning Objectives: At the conclusion of this educational program, learners will be able to:
- Describe the indications for interpreter use with patients and scope of practice for Approved Bilingual Providers
- Identify limitations and harms of ad-hoc interpretation
- Identify best practices in communication when working with an interpreter
In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician
Boston Children’s Hospital designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
Disclosure Policy
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.
Disclosure Statement
The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients:
Michele DeGrazia, PhD, RN, NNP, FAAN: 10% equity; Plagio LLC
Katherine Douglas, MD: None
Miriam Fox, MD, MPH: None
Kathleen Huth, MD, MPH: None
Sara Drumm, RN, CCRN: None
Emily Hamilton, MSN, CCRN, NP-C: None
Liza Li, PharmD: None
Kerry McDonnell, MSW, LICSW: None
Anna Gardner, PA-C, MPAS: None
Daniel O’Meara, MD: None
Joshua Dodderer, MD, MPH: None
Additional information
| Credit Type | |
|---|---|
| Duration | |
| Format | |
| Topic | Equity, Diversity, Inclusion, Family Medicine, General Pediatrics, Hospital Medicine, Medicine |
| Expiration Date | |
| Release Date |







